6-(5-diphenylphosphorylbenzo[a]carbazol-11-yl)benzimidazolo[1,2-c]quinazoline
C42H27N4OP — CID 134509238
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(5-diphenylphosphorylbenzo[a]carbazol-11-yl)benzimidazolo[1,2-c]quinazoline
6-(5-diphenylphosphorylbenzo[a]carbazol-11-yl)benzimidazolo[1,2-c]quinazoline (PubChem CID 134509238) has the molecular formula C42H27N4OP and a molecular weight of 634.68 g/mol. Its IUPAC name is 6-(5-diphenylphosphorylbenzo[a]carbazol-11-yl)benzimidazolo[1,2-c]quinazoline.
Molecular Properties
| Compound Name | 6-(5-diphenylphosphorylbenzo[a]carbazol-11-yl)benzimidazolo[1,2-c]quinazoline |
|---|---|
| PubChem CID | 134509238 |
| Molecular Formula | C42H27N4OP |
| Molecular Weight | 634.68 g/mol |
| Exact Mass | 634.19 |
| IUPAC Name | 6-(5-diphenylphosphorylbenzo[a]carbazol-11-yl)benzimidazolo[1,2-c]quinazoline |
| SMILES | O=P(c1ccccc1)(c1ccccc1)c1cc2c3ccccc3n(-c3nc4ccccc4c4nc5ccccc5n34)c2c2ccccc12 |
| InChI | InChI=1S/C42H27N4OP/c47-48(28-15-3-1-4-16-28,29-17-5-2-6-18-29)39-27-34-30-19-10-13-25-37(30)45(40(34)32-21-8-7-20-31(32)39)42-44-35-23-11-9-22-33(35)41-43-36-24-12-14-26-38(36)46(41)42/h1-27H |
| InChIKey | MZQVCUJSVRATKV-UHFFFAOYSA-N |
| XLogP | 8.93 |
| TPSA | 52.19 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 634.68 |
| LogP ≤ 5 | 8.93 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134509238 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.